A Phase 1 Trial of APG-157 in Oral Dysplasia

Recruiting Phase 2 NCT05865028

Study Description

A Study to Evaluate the Safety and Effectiveness of APG-157 in Reducing Tumor Size in Oral Dysplasia

Study Details

Registry ID:
NCT05865028
Conditions:
Oropharyngeal Dysplasia, Oral Cavity Dysplasia, Oral Carcinoma in Situ
Phase:
Phase 2
Target Enrollment:
32 participants
Start Date:
Age Range:
18–999 years
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →